OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma
Jie Liu, Wen‐Ping Lin, Yao Xiao, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111128-111128
Closed Access | Times Cited: 9
Jie Liu, Wen‐Ping Lin, Yao Xiao, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111128-111128
Closed Access | Times Cited: 9
Showing 9 citing articles:
Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Yayuan Deng, Mengjia Shi, Yi Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37060-e37060
Open Access | Times Cited: 31
Yayuan Deng, Mengjia Shi, Yi Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37060-e37060
Open Access | Times Cited: 31
PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation
Michal Kidacki, Christina Cho, Francesc López‐Giráldez, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Michal Kidacki, Christina Cho, Francesc López‐Giráldez, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment
He Lin, Meixuan Wan, Xin Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
He Lin, Meixuan Wan, Xin Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targets
Ke Liu, Jing Yu, X M Huang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Ke Liu, Jing Yu, X M Huang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
VISTA: A promising target for overcoming immune evasion in gynecologic cancers
Sicong Liu, Feng Ji, Yue Ding, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112655-112655
Closed Access | Times Cited: 3
Sicong Liu, Feng Ji, Yue Ding, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112655-112655
Closed Access | Times Cited: 3
Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification
Yi‐Ming Shi, Le Bao, Yanling Li, et al.
Journal of Affective Disorders (2024) Vol. 366, pp. 196-209
Closed Access | Times Cited: 2
Yi‐Ming Shi, Le Bao, Yanling Li, et al.
Journal of Affective Disorders (2024) Vol. 366, pp. 196-209
Closed Access | Times Cited: 2
VISTA-mediated immune evasion in cancer
Raymond Zhang, Tae Kon Kim
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 1
Raymond Zhang, Tae Kon Kim
Experimental & Molecular Medicine (2024)
Open Access | Times Cited: 1
Immunotherapeutic strategies beyond the PD-1/PD-L1 pathway in head and neck squamous cell carcinoma – A scoping review on current developments in agents targeting TIM-3, TIGIT, LAG-3, and VISTA
Ann‐Kristin Struckmeier, Martin Gosau, Ralf Smeets
Oral Oncology (2024) Vol. 161, pp. 107145-107145
Open Access | Times Cited: 1
Ann‐Kristin Struckmeier, Martin Gosau, Ralf Smeets
Oral Oncology (2024) Vol. 161, pp. 107145-107145
Open Access | Times Cited: 1
Clinical applications and perspectives of immune checkpoint inhibitors in oral squamous cell carcinoma
Liuyu Ru, Jiwei Zheng
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 535-547
Open Access
Liuyu Ru, Jiwei Zheng
ONCOLOGIE (2024) Vol. 26, Iss. 4, pp. 535-547
Open Access
